AQR Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.9M | Buy |
1,048,993
+102,227
| +11% | +$477K | ﹤0.01% | 1298 |
|
|
2025
Q1 | $5.2M | Buy |
946,766
+111,826
| +13% | +$614K | 0.01% | 1114 |
|
|
2024
Q4 | $2.83M | Sell |
834,940
-233,176
| -22% | -$790K | ﹤0.01% | 1341 |
|
|
2024
Q3 | $3.04M | Sell |
1,068,116
-124,964
| -10% | -$356K | ﹤0.01% | 1289 |
|
|
2024
Q2 | $2.68M | Buy |
1,193,080
+52,074
| +5% | +$117K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $2.52M | Buy |
1,141,006
+867,784
| +318% | +$1.92M | ﹤0.01% | 1303 |
|
|
2023
Q4 | $642K | Buy |
273,222
+230,942
| +546% | +$543K | ﹤0.01% | 1778 |
|
|
2023
Q3 | $78.6K | Buy |
42,280
+28,612
| +209% | +$53.2K | ﹤0.01% | 2254 |
|
|
2023
Q2 | $35.8K | Sell |
13,668
-17,898
| -57% | -$46.9K | ﹤0.01% | 2169 |
|
|
2023
Q1 | $51.5K | Sell |
31,566
-18,688
| -37% | -$30.5K | ﹤0.01% | 2142 |
|
|
2022
Q4 | $66.8K | Buy |
50,254
+29,712
| +145% | +$39.5K | ﹤0.01% | 2162 |
|
|
2022
Q3 | $32K | Buy |
+20,542
| New | +$32K | ﹤0.01% | 2159 |
|